Helius Medical Technologies Inc (HSDT) Stock Price, Quote & News

Company Profile

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in c...

Industry: Medical Devices

Sector: Healthcare

Phone: 215 944 6100

Website: heliusmedical.com

Address:

642 Newtown Yardley Road, Suite 100, Newtown, United States

Lay1a Jul. 16 at 6:49 PM

$HSDT Maybe big money said - it's not going under $7 so lets start buying slowly until it hits $10 then we will pop it to $20 and trigger a short covering to $40-50.

0 · Reply

Hassan77 Jul. 16 at 5:55 PM

$HSDT Is something wrong? Helius is actually moving in the right direction…

1 · Reply

Super_Marioo Jul. 16 at 4:39 PM

$HSDT - normally I am not greedy and take my profits after a pop. however if this pops 100% on a good solid PR I have a feeling the gains may surprise many of you over the course of weeks and months. I say this due to the massive unwarranted drop from $200 to current in just 4 weeks and the numerous upcoming potential catalysts I outlined in my prior post.

1 · Reply

Lay1a Jul. 16 at 4:19 PM

$HSDT I wonder what a short squeeze would look like with there are only 700k outstanding shares and no one wants to sell. Would we open up at $25, $50, $75 or $100?

0 · Reply

Lay1a Jul. 16 at 3:36 PM

$HSDT Anyone that was going to be shaken out already sold under $7.50. Those who are left are not selling so hopefully buying volume will now exceed selling volume. Up we go.

0 · Reply

loosenutz Jul. 16 at 2:50 PM

$HSDT I noticed that Schwab closed out my position, then I realized why... The 10K shares I bought in 2022 were now less than 1 share due to all the RS so they had to sell it... WHAT A SCAM!!

2 · Reply

Lay1a Jul. 16 at 2:43 PM

$HSDT Seems I made a good decision yesterday. Now lets wait for the pop to $50.

0 · Reply

Lay1a Jul. 16 at 2:36 PM

$HSDT Sure looks like $7 was the bottom but more buying volume and a move toward $10 will confirm it.

0 · Reply

sjp78 Jul. 16 at 2:06 PM

$HSDT waiting for my money back

1 · Reply

Iiii1ii Jul. 16 at 2:01 PM

$HSDT HSDT Short Squeeze Imminent $70+

0 · Reply

Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements

Jul 8, 2025, 8:01 AM EDT - 8 days ago

Helius Medical Technologies, Sunrun And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

RUN

Jun 27, 2025, 8:30 AM EDT - 19 days ago

Helius Medical Technologies Announces Reverse Stock Split

Jun 16, 2025, 7:00 AM EDT - 4 weeks ago

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device

Jun 12, 2025, 7:00 AM EDT - 4 weeks ago

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

Jun 11, 2025, 7:00 AM EDT - 5 weeks ago

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

Jun 4, 2025, 9:12 PM EDT - 5 weeks ago

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering

Jun 4, 2025, 7:00 AM EDT - 6 weeks ago

Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria

May 20, 2025, 7:00 AM EDT - 2 months ago

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

May 12, 2025, 7:00 AM EDT - 2 months ago

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Mar 13, 2025, 7:00 AM EDT - 4 months ago

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary

Mar 11, 2025, 7:00 AM EDT - 4 months ago

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Jan 22, 2025, 7:00 AM EST - 6 months ago

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Jan 21, 2025, 8:00 PM EST - 6 months ago

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

Dec 23, 2024, 7:00 AM EST - 7 months ago

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

Nov 18, 2024, 8:01 AM EST - 8 months ago

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Oct 14, 2024, 5:00 PM EDT - 9 months ago

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Aug 16, 2024, 5:00 PM EDT - 11 months ago

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Aug 12, 2024, 9:33 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 4:36 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024

Jun 17, 2024, 7:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke

May 31, 2024, 12:30 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference

May 23, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

May 20, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

May 13, 2024, 7:21 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

May 10, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

May 6, 2024, 10:15 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

Apr 24, 2024, 9:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Apr 3, 2024, 7:55 AM EDT - 1 year ago

Helius Medical stock rallies 40%: explore why

Apr 3, 2024, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

Mar 28, 2024, 8:45 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 15, 2024, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

Mar 12, 2024, 8:59 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

Mar 7, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

Mar 4, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Feb 6, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

Feb 5, 2024, 7:05 AM EST - 1 year ago

Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists' Ability to Customize PoNS Therapy® to Improve Gait in People with MS

Jan 11, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Nov 30, 2023, 7:47 AM EST - 1 year ago

Helius Medical Technologies to Present at NobleCon19 Annual Conference

Nov 12, 2023, 8:11 AM EST - 1 year ago

Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 7:05 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

Nov 2, 2023, 5:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

Oct 12, 2023, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices

Oct 2, 2023, 7:05 AM EDT - 1 year ago

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

Sep 28, 2023, 7:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece

Sep 21, 2023, 7:05 AM EDT - 1 year ago

Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference

Sep 20, 2023, 7:05 AM EDT - 1 year ago

University of Montreal's School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery

Lay1a Jul. 16 at 6:49 PM

$HSDT Maybe big money said - it's not going under $7 so lets start buying slowly until it hits $10 then we will pop it to $20 and trigger a short covering to $40-50.

0 · Reply

Hassan77 Jul. 16 at 5:55 PM

$HSDT Is something wrong? Helius is actually moving in the right direction…

1 · Reply

Super_Marioo Jul. 16 at 4:39 PM

1 · Reply

Lay1a Jul. 16 at 4:19 PM

$HSDT I wonder what a short squeeze would look like with there are only 700k outstanding shares and no one wants to sell. Would we open up at $25, $50, $75 or $100?

0 · Reply

Lay1a Jul. 16 at 3:36 PM

$HSDT Anyone that was going to be shaken out already sold under $7.50. Those who are left are not selling so hopefully buying volume will now exceed selling volume. Up we go.

0 · Reply

loosenutz Jul. 16 at 2:50 PM

$HSDT I noticed that Schwab closed out my position, then I realized why... The 10K shares I bought in 2022 were now less than 1 share due to all the RS so they had to sell it... WHAT A SCAM!!

2 · Reply

Lay1a Jul. 16 at 2:43 PM

$HSDT Seems I made a good decision yesterday. Now lets wait for the pop to $50.

0 · Reply

Lay1a Jul. 16 at 2:36 PM

$HSDT Sure looks like $7 was the bottom but more buying volume and a move toward $10 will confirm it.

0 · Reply

sjp78 Jul. 16 at 2:06 PM

$HSDT waiting for my money back

1 · Reply

Iiii1ii Jul. 16 at 2:01 PM

$HSDT HSDT Short Squeeze Imminent $70+

0 · Reply

Hassan77 Jul. 16 at 1:59 PM

$HSDT Back over $8..lets see if we get some more green today

1 · Reply

sjp78 Jul. 16 at 1:58 PM

$HSDT look NUWE, spiked as soon as impatient sold. When is our day? waiting

0 · Reply

Got1me99 Jul. 16 at 10:49 AM

$HSDT $2.50 gap between bid/ask 👀😅

1 · Reply

Miok Jul. 16 at 10:41 AM

$HSDT did the MC just jump from 500k to $5MM mc?

1 · Reply

Super_Marioo Jul. 16 at 12:24 AM

$HSDT - this is not a scam company even though the recent share price dump might make you believe. recent decline actually started on Jan 31th of this year. however there are numerous potential multi-bagger massive catalysts - fda submission for stroke authorization, top line stroke study results, pons study results, insurance reimbursement coverage, etc.

1 · Reply

Zackpedia Jul. 15 at 10:51 PM

$HSDT Support at 7, resistance at 7.74, you know what to do

0 · Reply

Zackpedia Jul. 15 at 10:05 PM

$HSDT You could’ve sold when I alerted and bought back at 7 today if you wanted, hit Follow and subscribe to get my alerts on time and make money

1 · Reply

Hassan77 Jul. 15 at 8:48 PM

$HSDT The ball is in managements court now. We are at their mercy. I do feel like they will drag this low volume manipulation out until many lose patience and sell out of frustration…me? im planning on going down with the ship if I have to…I want my 10k back with interest if possible

1 · Reply

Lay1a Jul. 15 at 8:34 PM

$HSDT I doubled my position today in an effort to bring my cost basis down to $9. Just wanted my cost basis in the single digits lol. Now let's get a positive PR!

0 · Reply

Lay1a Jul. 15 at 8:16 PM

$HSDT Closed green! AH gap between ask and bid is 40c.

0 · Reply

ShadowSnake Jul. 15 at 7:06 PM

$HSDT they took $TNXP to $6 after their reverse split and it’s at $45 today. I’ll hold for now and will look to add under $7…

1 · Reply

Hassan77 Jul. 15 at 6:50 PM

$HSDT Volume coming in late..maybe news AH’s?

0 · Reply

Market Cap	100,000.00
Revenue (ttm)	520,000.00
Net Income (ttm)	-11.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,257.69%
Debt to Equity Ratio	0.00

Volume	66,771
Avg Vol	182,641
Day's Range	N/A - N/A
Shares Out	14,000.00
Stochastic %K	20%
Beta	0.86
Analysts	Hold
Price Target	$4.00